Skip to content

Clinical trials

Terminated Phase 2 Major Depressive Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Phase: Phase 2 Status: Terminated Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20052
20061
20071
20084
20091
20104
20112
20122
20133
20142
20163
20173
20182
20202
20212
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated38

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Mental Health (NIMH)4
Janssen Research & Development, LLC3
AstraZeneca2
Brigham and Women's Hospital2
GlaxoSmithKline2
Naurex, Inc, an affiliate of Allergan plc2
Pfizer2
AbbVie (prior sponsor, Abbott)1
Axsome Therapeutics, Inc.1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder38
Depressive Disorder, Treatment-Resistant6
Depressive Disorder5
Bipolar Disorder3
Mood Disorders3
Recurrence2
Borderline Personality Disorder1
Brain Injuries, Traumatic1
Inflammation1
Mental Disorders1

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.